Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA) and FDAs technical assistance on DAIA; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Laboratory Fee Schedule; federal policy relating to drug development; federal policy relating to appropriating funds for the National Evaluation System for health Technology Coordinating Center (NESTcc); federal policy relating to surprise medical bills, including the discussion draft of the Protecting Patients from Surprise Medical Billing Act, and H.R. 6470 / S. 3158, federal policy relating to appropriating funds for HHS for FY 2019. Federal policy related to possible DOT actions regarding cargo transport.
HCR - Health Issues TRA - Transportation
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS
531 South Spring Street, Burlington, NC, 27215, US
DONALD HORTON KATHERINE PREGEL DONALD HORTON KATHERINE PREGEL